Press Releases

AdvaMed leads Global Effort to Push Back on Lithium Battery Transport Restrictions

WASHINGTON, D.C. – As the International Civil Aviation Organization (ICAO) Dangerous Goods Panel meets this week, AdvaMed, the Medtech Association, led a group of 24 global medtech organizations in expressing concerns about the panel’s proposed regulations on the transport of dangerous goods aboard aircraft. The proposed regulations would negatively impact the international air shipments of medical devices containing batteries.

From the letter to ICAO: For patients requiring timely access to life-critical devices such as defibrillators, implantable medical devices (e.g., pacemakers and neuromodulators), and wearable medical devices (e.g., heart monitors, heart pumps, ventilators), a disruption to the supply chain poses serious threats to public health.

“The medical device community produces state-of-the-art products that are already heavily regulated by international agencies to the highest standards of safety and effectiveness. The medical device industry is not aware of a single aviation incident involving lithium battery-powered medical devices. To the contrary, there has been consistent concern about the public health risks of restricting air shipment of medical device batteries and has allowed for exemptions for life-saving medical devices to be flown on passenger flights.”

In the letter, the groups outline the issues with requiring shipments of rechargeable lithium ion batteries packed with or contained in equipment to be shipped at the lowest state of charge not to exceed 30%, including implications to patient care and operational costs for medtech companies:

Read the full letter here.